Actinium Pharmaceuticals HomeAboutTechnologyProduct PipelinePressAbstractsContact
Technology

Actinium Pharmaceuticals’ Technology

 Background
 Cancer Cell Killing Agents
 Comparison of Alpha And Beta Emitters
 Components of Immunotherapy
 Assembly of Immunotherapeutic Agents


A Comparison of Alpha And Beta Emitters

Use of alpha-particles as the cancer killing agents instead of beta particles is more attractive for a combination of reasons:
• The alpha's energy is 30 x greater than that of a beta
(typically 6 MeV versus 200 keV)
• The electric charge is double (+2 versus -1)
• The mass is 7,000 x heavier (4 mass units versus 1/1800)


The result being the effective range of alpha particles in tissue is about 5 cell diameters compared with hundreds or thousands of cell diameters for beta particles.
As to cell killing:
• The amount of energy dissipated per unit track length of an alpha particle is 1000x greater than that for beta particles.
• Non-elastic collisions cause 3x as much cell killing per unit of energy dissipated in tissue, proportionately increasing the effectiveness of cell killing.
• Because the effective range for alpha particles is <5 cell diameters, the killing is confined to tumor cells and thus collateral damage to normal tissue is minimized.
As to side effects:
• The short penetration range and the short half-life of the therapeutic alpha particle emitting isotopes lead to no significant effect on normal tissues and no residual buildup of radiation in the body resulting in a far greater overall health benefit and improved quality of life.

<BACK TO TOP >